ID   PLCD3_HUMAN             Reviewed;         789 AA.
AC   Q8N3E9; Q8TEC1; Q8TF37; Q96FL6;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   02-OCT-2007, sequence version 3.
DT   10-MAY-2017, entry version 147.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-delta-3;
DE   AltName: Full=Phospholipase C-delta-3;
DE            Short=PLC-delta-3;
GN   Name=PLCD3; Synonyms=KIAA1964;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 13-789.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33-789.
RC   TISSUE=Brain;
RX   PubMed=11853319; DOI=10.1093/dnares/8.6.319;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXII.
RT   The complete sequences of 50 new cDNA clones which code for large
RT   proteins.";
RL   DNA Res. 8:319-327(2001).
RN   [5]
RP   PURIFICATION.
RX   PubMed=9360711;
RA   Pawelczyk T., Matecki A.;
RT   "Expression, purification and kinetic properties of human recombinant
RT   phospholipase C delta 3.";
RL   Acta Biochim. Pol. 44:221-229(1997).
RN   [6]
RP   PURIFICATION.
RX   PubMed=9056492; DOI=10.1006/prep.1996.0682;
RA   Ghosh S., Pawelczyk T., Lowenstein J.M.;
RT   "Phospholipase C isoforms delta 1 and delta 3 from human fibroblasts.
RT   High-yield expression in Escherichia coli, simple purification, and
RT   properties.";
RL   Protein Expr. Purif. 9:262-278(1997).
RN   [7]
RP   SUBCELLULAR LOCATION, COFACTOR, AND ENZYME REGULATION.
RX   PubMed=9799116; DOI=10.1046/j.1432-1327.1998.2570169.x;
RA   Pawelczyk T., Matecki A.;
RT   "Localization of phospholipase C delta3 in the cell and regulation of
RT   its activity by phospholipids and calcium.";
RL   Eur. J. Biochem. 257:169-177(1998).
RN   [8]
RP   IDENTIFICATION.
RX   PubMed=10702670;
RA   Kim H., Suh P.-G., Ryu S.H., Park S.H.;
RT   "Assignment of the human PLC delta3 gene (PLCD3) to human chromosome
RT   band 17q21 by fluorescence in situ hybridization.";
RL   Cytogenet. Cell Genet. 87:209-210(1999).
RN   [9]
RP   ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, AND
RP   DOMAIN PH.
RX   PubMed=10336610; DOI=10.1046/j.1432-1327.1999.00388.x;
RA   Pawelczyk T., Matecki A.;
RT   "Phospholipase C-delta3 binds with high specificity to
RT   phosphatidylinositol 4,5-bisphosphate and phosphatidic acid in bilayer
RT   membranes.";
RL   Eur. J. Biochem. 262:291-298(1999).
RN   [10]
RP   INDUCTION.
RX   PubMed=11500033; DOI=10.1006/bbrc.2001.5371;
RA   Lin F.-G., Cheng H.-F., Lee I.-F., Kao H.-J., Loh S.-H., Lee W.-H.;
RT   "Downregulation of phospholipase C delta3 by cAMP and calcium.";
RL   Biochem. Biophys. Res. Commun. 286:274-280(2001).
RN   [11]
RP   DOMAIN C2.
RX   PubMed=11706040; DOI=10.1074/jbc.M109705200;
RA   Ananthanarayanan B., Das S., Rhee S.-G., Murray D., Cho W.;
RT   "Membrane targeting of C2 domains of phospholipase C-delta isoforms.";
RL   J. Biol. Chem. 277:3568-3575(2002).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=15505048; DOI=10.1167/iovs.04-0084;
RA   Landreville S., Coulombe S., Carrier P., Gelb M.H., Guerin S.L.,
RA   Salesse C.;
RT   "Expression of phospholipases A2 and C in human corneal epithelial
RT   cells.";
RL   Invest. Ophthalmol. Vis. Sci. 45:3997-4003(2004).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17041247; DOI=10.1093/jb/mvj209;
RA   Naito Y., Okada M., Yagisawa H.;
RT   "Phospholipase C isoforms are localized at the cleavage furrow during
RT   cytokinesis.";
RL   J. Biochem. 140:785-791(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; SER-496 AND
RP   SER-573, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Hydrolyzes the phosphatidylinositol 4,5-bisphosphate
CC       (PIP2) to generate 2 second messenger molecules diacylglycerol
CC       (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG mediates the
CC       activation of protein kinase C (PKC), while IP3 releases Ca(2+)
CC       from intracellular stores. Essential for trophoblast and placental
CC       development. May participate in cytokinesis by hydrolyzing PIP2 at
CC       the cleavage furrow.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol. {ECO:0000269|PubMed:10336610}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000305|PubMed:9799116};
CC       Note=Binds 3 Ca(2+) ions per subunit. Two of the Ca(2+) ions are
CC       bound to the C2 domain. {ECO:0000305|PubMed:9799116};
CC   -!- ENZYME REGULATION: Strongly activated by phosphatidic acid.
CC       Inhibited by phosphatidylethanolamine (PtdEtn),
CC       phosphatidylcholine (PtdCho), sphingomyelin and phosphatidylserine
CC       (PtdSer). {ECO:0000269|PubMed:10336610,
CC       ECO:0000269|PubMed:9799116}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=105.3 uM for PIP2 {ECO:0000269|PubMed:10336610};
CC         Vmax=28.5 umol/min/mg enzyme {ECO:0000269|PubMed:10336610};
CC   -!- SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.
CC       Cytoplasm. Cleavage furrow. Note=Localizes at the cleavage furrow
CC       during cytokinesis.
CC   -!- TISSUE SPECIFICITY: Present in corneal epithelial cells (at
CC       protein level). {ECO:0000269|PubMed:15505048}.
CC   -!- INDUCTION: Down-regulated by Ca(2+) and cAMP.
CC       {ECO:0000269|PubMed:11500033}.
CC   -!- DOMAIN: The C2 domain is a Ca(2+)-dependent membrane-targeting
CC       module.
CC   -!- DOMAIN: The PH domain mediates interaction with the surface
CC       membrane by binding to PIP2.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK074240; BAB85029.1; -; mRNA.
DR   EMBL; BC010668; AAH10668.2; -; mRNA.
DR   EMBL; BC072384; AAH72384.1; -; mRNA.
DR   EMBL; AL834392; CAD39054.2; -; mRNA.
DR   EMBL; AB075844; BAB85550.1; -; mRNA.
DR   CCDS; CCDS74077.1; -.
DR   RefSeq; NP_588614.1; NM_133373.4.
DR   UniGene; Hs.380094; -.
DR   ProteinModelPortal; Q8N3E9; -.
DR   SMR; Q8N3E9; -.
DR   BioGrid; 125222; 14.
DR   IntAct; Q8N3E9; 3.
DR   MINT; MINT-1193970; -.
DR   STRING; 9606.ENSP00000313731; -.
DR   SwissLipids; SLP:000001067; -.
DR   iPTMnet; Q8N3E9; -.
DR   PhosphoSitePlus; Q8N3E9; -.
DR   SwissPalm; Q8N3E9; -.
DR   BioMuta; PLCD3; -.
DR   DMDM; 158706388; -.
DR   EPD; Q8N3E9; -.
DR   MaxQB; Q8N3E9; -.
DR   PaxDb; Q8N3E9; -.
DR   PeptideAtlas; Q8N3E9; -.
DR   PRIDE; Q8N3E9; -.
DR   Ensembl; ENST00000619929; ENSP00000479636; ENSG00000161714.
DR   GeneID; 113026; -.
DR   KEGG; hsa:113026; -.
DR   UCSC; uc032fjs.2; human.
DR   CTD; 113026; -.
DR   DisGeNET; 113026; -.
DR   GeneCards; PLCD3; -.
DR   HGNC; HGNC:9061; PLCD3.
DR   HPA; HPA025711; -.
DR   MIM; 608795; gene.
DR   neXtProt; NX_Q8N3E9; -.
DR   OpenTargets; ENSG00000161714; -.
DR   PharmGKB; PA33389; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOGENOM; HOG000006871; -.
DR   HOVERGEN; HBG053610; -.
DR   InParanoid; Q8N3E9; -.
DR   KO; K05857; -.
DR   OMA; VVYCHAT; -.
DR   OrthoDB; EOG091G02KH; -.
DR   PhylomeDB; Q8N3E9; -.
DR   TreeFam; TF313216; -.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   ChiTaRS; PLCD3; human.
DR   GeneWiki; PLCD3; -.
DR   GenomeRNAi; 113026; -.
DR   PRO; PR:Q8N3E9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000161714; -.
DR   CleanEx; HS_PLCD3; -.
DR   ExpressionAtlas; Q8N3E9; baseline and differential.
DR   Genevisible; Q8N3E9; HS.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR028406; PLC-delta3.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF141; PTHR10336:SF141; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Cytoplasm; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transducer.
FT   CHAIN         1    789       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase delta-3.
FT                                /FTId=PRO_0000306821.
FT   DOMAIN       63    172       PH.
FT   DOMAIN      182    217       EF-hand 1.
FT   DOMAIN      218    253       EF-hand 2.
FT   DOMAIN      250    285       EF-hand 3.
FT   DOMAIN      337    482       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      528    644       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      647    752       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   CA_BIND     195    206       1. {ECO:0000255}.
FT   CA_BIND     231    242       2. {ECO:0000255}.
FT   REGION       73    101       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    352    352       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    397    397       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   METAL       353    353       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       382    382       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       384    384       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       431    431       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       683    683       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       685    685       Calcium 2. {ECO:0000250}.
FT   METAL       709    709       Calcium 2. {ECO:0000250}.
FT   METAL       738    738       Calcium 3. {ECO:0000250}.
FT   METAL       739    739       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       740    740       Calcium 3. {ECO:0000250}.
FT   BINDING     480    480       Substrate. {ECO:0000250}.
FT   BINDING     482    482       Substrate. {ECO:0000250}.
FT   BINDING     557    557       Substrate. {ECO:0000250}.
FT   BINDING     584    584       Substrate. {ECO:0000250}.
FT   MOD_RES     105    105       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     573    573       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     652    652       P -> L (in dbSNP:rs734921).
FT                                /FTId=VAR_035316.
FT   CONFLICT    207    207       I -> T (in Ref. 3; CAD39054).
FT                                {ECO:0000305}.
SQ   SEQUENCE   789 AA;  89258 MW;  C6901404D2C9D070 CRC64;
     MLCGRWRRCR RPPEEPPVAA QVAAQVAAPV ALPSPPTPSD GGTKRPGLRA LKKMGLTEDE
     DVRAMLRGSR LRKIRSRTWH KERLYRLQED GLSVWFQRRI PRAPSQHIFF VQHIEAVREG
     HQSEGLRRFG GAFAPARCLT IAFKGRRKNL DLAAPTAEEA QRWVRGLTKL RARLDAMSQR
     ERLDHWIHSY LHRADSNQDS KMSFKEIKSL LRMVNVDMND MYAYLLFKEC DHSNNDRLEG
     AEIEEFLRRL LKRPELEEIF HQYSGEDRVL SAPELLEFLE DQGEEGATLA RAQQLIQTYE
     LNETAKQHEL MTLDGFMMYL LSPEGAALDN THTCVFQDMN QPLAHYFISS SHNTYLTDSQ
     IGGPSSTEAY VRAFAQGCRC VELDCWEGPG GEPVIYHGHT LTSKILFRDV VQAVRDHAFT
     LSPYPVILSL ENHCGLEQQA AMARHLCTIL GDMLVTQALD SPNPEELPSP EQLKGRVLVK
     GKKLPAARSE DGRALSDREE EEEDDEEEEE EVEAAAQRRL AKQISPELSA LAVYCHATRL
     RTLHPAPNAP QPCQVSSLSE RKAKKLIREA GNSFVRHNAR QLTRVYPLGL RMNSANYSPQ
     EMWNSGCQLV ALNFQTPGYE MDLNAGRFLV NGQCGYVLKP ACLRQPDSTF DPEYPGPPRT
     TLSIQVLTAQ QLPKLNAEKP HSIVDPLVRI EIHGVPADCA RQETDYVLNN GFNPRWGQTL
     QFQLRAPELA LVRFVVEDYD ATSPNDFVGQ FTLPLSSLKQ GYRHIHLLSK DGASLSPATL
     FIQIRIQRS
//
